|
Dr. Nader is responsible for managing the company's worldwide R&D Commercial Operations Manufacturing and Regulatory Affairs. Previously he was a venture partner at Care Capital LLC and chief medical officer of its Clinical Development Capital unit. Prior experience includes senior vice president integrated healthcare markets and North America medical and regulatory affairs with Aventis Pharmaceuticals as well as similar positions at Hoechst Marion Roussel and its predecessor companies. Before joining Hoechst Marion Roussel Dr Nader served as head of global commercial operations at the Pasteur Vaccines division of Rhone-Poulenc. Dr. Nader joined NPS in June of 2006. | 